BioCentury
ARTICLE | Company News

Coulter and Cobra to develop gene expression technology

October 3, 2000 7:00 AM UTC

CLTR and Cobra Therapeutics, a subsidiary of ML Laboratories (LSE:MLB), will collaborate to develop and commercialize Cobra's gene expression technology. Cobra's Ubiquitous Chromatin Opening Elements ...